Compare TBPH & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TBPH | MBWM |
|---|---|---|
| Founded | 2013 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 884.4M |
| IPO Year | 2013 | 1997 |
| Metric | TBPH | MBWM |
|---|---|---|
| Price | $16.40 | $52.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $18.40 | ★ $55.67 |
| AVG Volume (30 Days) | ★ 282.6K | 87.9K |
| Earning Date | 05-04-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.08% |
| EPS Growth | ★ 279.13 | 10.95 |
| EPS | N/A | ★ 1.32 |
| Revenue | ★ $15,386,000.00 | N/A |
| Revenue This Year | $8.46 | $20.28 |
| Revenue Next Year | N/A | $4.67 |
| P/E Ratio | ★ N/A | $39.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.10 | $42.17 |
| 52 Week High | $21.03 | $55.77 |
| Indicator | TBPH | MBWM |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 55.16 |
| Support Level | $16.14 | $49.25 |
| Resistance Level | $17.21 | $52.79 |
| Average True Range (ATR) | 0.38 | 1.28 |
| MACD | -0.07 | 0.13 |
| Stochastic Oscillator | 29.31 | 79.58 |
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.